Literature DB >> 28133623

Circadian Gating of the Mammalian Cell Cycle Restriction Point: A Mathematical Analysis.

Jing Su1, Michael A Henson2.   

Abstract

A critical decision in the mammalian cell cycle is whether to pass through the restriction point (R-point) or enter the cell cycle. In this letter, we modeled the decision-making system of the mammalian cell cycle entry and the simulated circadian regulation of the R-point driven by external epithelial growth factor (EGF) patterns. Our conceptual model replicated key signaling behaviors observed experimentally, suggesting that the proposed network captured the essential system features. The model revealed the dramatic importance of the EGF dynamics on promoting cell proliferation, showed that the EGF signal duration was more important than the signal strength for driving cells past the R-point, and suggested that the loss of circadian control of the cell cycle entry could be associated with cancer development.

Entities:  

Keywords:  Cancer; circadian rhythm; systems biology

Year:  2015        PMID: 28133623      PMCID: PMC5271574          DOI: 10.1109/LLS.2015.2449511

Source DB:  PubMed          Journal:  IEEE Life Sci Lett


  18 in total

1.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.

Authors:  Birgit Schoeberl; Claudia Eichler-Jonsson; Ernst Dieter Gilles; Gertraud Müller
Journal:  Nat Biotechnol       Date:  2002-04       Impact factor: 54.908

2.  Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.

Authors:  Michael P DiGiovanna; David F Stern; Susan M Edgerton; Steve G Whalen; Dan Moore; Ann D Thor
Journal:  J Clin Oncol       Date:  2005-02-20       Impact factor: 44.544

3.  Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.

Authors:  Bart S Hendriks; Lee K Opresko; H Steven Wiley; Douglas Lauffenburger
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

4.  Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.

Authors:  W S Chen; C S Lazar; K A Lund; J B Welsh; C P Chang; G M Walton; C J Der; H S Wiley; G N Gill; M G Rosenfeld
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

Review 5.  Rhythms in human bone marrow and blood cells.

Authors:  Rune Smaaland; Robert B Sothern; Ole D Laerum; Jenny Foss Abrahamsen
Journal:  Chronobiol Int       Date:  2002-01       Impact factor: 2.877

6.  Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer.

Authors:  E Haus; L Dumitriu; G Y Nicolau; S Bologa; L Sackett-Lundeen
Journal:  Chronobiol Int       Date:  2001-07       Impact factor: 2.877

7.  Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.

Authors:  Bart S Hendriks; Gayla Orr; Alan Wells; H Steven Wiley; Douglas A Lauffenburger
Journal:  J Biol Chem       Date:  2004-11-29       Impact factor: 5.157

8.  Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells.

Authors:  John F Timms; Sarah L White; Michael J O'Hare; Michael D Waterfield
Journal:  Oncogene       Date:  2002-09-26       Impact factor: 9.867

9.  Toward a detailed computational model for the mammalian circadian clock.

Authors:  Jean-Christophe Leloup; Albert Goldbeter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

10.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.

Authors:  Marc R Birtwistle; Mariko Hatakeyama; Noriko Yumoto; Babatunde A Ogunnaike; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.